Biomarkers Index

Abbreviation: Definition: Cancer Correlations: Treatment Correlations:
c-MET

also known as mesenchymal epithelial transition factor (MET) or hepatocyte growth factor receptor (HGFR) - a proto-oncogene active in cell signaling, c-MET promotes cancer cell growth and multiplication. Cancers that may benefit from testing for this biomarker: lung (non-small cell), ovarian

Lung, Ovarian

erlotinib (Tarceva®), gefitinib (Iressa®)

c-Kit

tyrosine-protein kinase Kit, also known as CD117 or mast/stem cell growth factor receptor (SCFR) - a proto-oncogene that interacts with cell growth factors, c-Kit plays a role in cell survival, multiplication and differentiation. Cancers that may benefit from testing for this biomarker: GIST (gastrointestinal stromal tumor), skin (melanoma), blood (acute myelogenous leukemia)

Blood, Gastric, Skin

imatinib (Gleevec®), sorafenib (Nexavar®), sunitinib (Sutent®)

BRCA1

Breast cancer 1, early onset - a tumor suppressor gene, BRCA1 helps to repair DNA or destroys cells if DNA cannot be repaired; its expression in many cancers can indicate potential response to certain types of therapies. Cancers that may benefit from testing for this biomarker: lung, ovarian, breast

Breast, Lung, Ovarian

cisplatin (Platinol®)

AR

androgen receptor - part of the nuclear hormone receptor superfamily, active in cell signaling and therefore cell multiplication and growth. Cancers that may benefit from testing for this biomarker: prostate, breast, ovarian, bladder, lung (non-small cell)

Bladder, Breast, Lung, Ovarian, Prostate

bicalutamide (Casodex®), flutamide (Eulexin®), goserelin (Zoladex®), leuprolide (Lupron®), abarelix (Plenaxis®), gonadorelin (Factrel®)

ALK

anaplastic lymphoma kinase - an enzyme that can form an oncogenic fusion gene with EML4. Cancers that may benefit from testing for this biomarker: lung (non-small cell), lymphoma (anaplastic large-cell), nervous system (familial neuroblastoma).

Lung, Lymphoma, Nervous System

crizotinib (Xalkori®), pemetrexed (Alimta®)

BRAF

also know as v-raf murine sarcoma viral oncogene homolog B1 - a proto-oncogene in the RAF/MIL family of molecules active in MAP/ERK cell signaling, promotes cell multiplication and growth. Cancers that may benefit from testing for this biomarker: colon, skin (melanoma), lung (adenocarcinoma), thyroid (papillary thyroid carcinoma), nervous system (pleomorphic xanthoastrocytomas with and without anaplasia)

Colorectal, Lung, Nervous System, Skin, Thyroid

cetuximab (Erbitux®), panitumumab (Vectibix®), vemurafenib (Zelboraf®)

FISH, IHC